Literature DB >> 24359986

Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation.

Kenar D Jhaveri1, Hitesh H Shah2, Chinmay Patel2, Aditya Kadiyala2, Michael B Stokes2, Jai Radhakrishnan2.   

Abstract

Many solid and hematological malignancies have been associated with different glomerular diseases. Several case reports and case series of cancer-associated glomerular diseases have shown that treating the cancer may lead to resolution of the glomerular process. Hence, knowledge and approach to cancer-associated glomerular diseases is important for both the caring nephrologists and the cancer specialists. While membranous nephropathy has been classically associated with solid malignancies, minimal change disease has been commonly described with hematologic malignancies, especially non-Hodgkin's lymphoma. Membranoproliferative glomerulonephritis is increasingly being recognized to be associated with chronic hematologic malignancies such as chronic lymphocytic leukemia. In this article, we review various cancer-associated glomerular diseases and their pathogenesis as well as principles of treatment. In addition, we also review glomerular diseases seen after chemotherapy and hematopoietic stem cell transplantation.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Chemotherapy; Graft versus host disease; Hematopoietic stem cell transplantation; Paraneoplastic glomerulonephritis

Mesh:

Substances:

Year:  2014        PMID: 24359986     DOI: 10.1053/j.ackd.2013.08.003

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  9 in total

1.  Monoclonal B lymphocytosis and minimal change disease: a new monoclonal B-cell disorder of renal significance?

Authors:  Margaux Van Wynsberghe; Pascal Lenain; Fanny Drieux; Dominique Guerrot; Dominique Bertrand
Journal:  J Nephrol       Date:  2017-12-21       Impact factor: 3.902

2.  Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience.

Authors:  Paolo Strati; Samih H Nasr; Nelson Leung; Curtis A Hanson; Kari G Chaffee; Susan M Schwager; Sara J Achenbach; Timothy G Call; Sameer A Parikh; Wei Ding; Neil E Kay; Tait D Shanafelt
Journal:  Haematologica       Date:  2015-06-18       Impact factor: 9.941

3.  Polyangiitis with granulomatosis as a paraneoplastic syndrome of B-cell lymphoma of the lacrimal gland.

Authors:  Beatriz Wills Sanín; Yenny R Cárdenas Bolivar; Jose J Carvajal; Guillermo E Quintero; Rafael Andrade
Journal:  Case Rep Hematol       Date:  2014-12-18

4.  Membranous nephropathy succeeding autologous hematopoietic stem cell transplant: a case report.

Authors:  Sanda Mrabet; Narjess Ben Aicha; Nihed Abdessayed; Moncef Mokni; Abdellatif Achour
Journal:  BMC Nephrol       Date:  2018-03-09       Impact factor: 2.388

5.  The validation of a newly developed Arabic scale to assess patient-reported side-effects of antineoplastic agents.

Authors:  Reem Alhaider; Yazed AlRuthia; Ghadah Almuaythir; Wejdan Alsharif; Hala Alrasheed; Shatha Asiri; Bushra Alghamdi; Khalid Alsaleh; Fahad D Alosaimi; Sultan Alghadeer; Azher Arafah
Journal:  Saudi Pharm J       Date:  2019-05-22       Impact factor: 4.330

6.  Secondary Membranous Nephropathy. A Narrative Review.

Authors:  Gabriella Moroni; Claudio Ponticelli
Journal:  Front Med (Lausanne)       Date:  2020-12-03

7.  Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma.

Authors:  Praveen Ratanasrimetha; Vikas D Reddy; Jaya Kala; Amanda Tchakarov; William F Glass; Pavlos Msaouel; Jamie S Lin
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

8.  Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period.

Authors:  Christopher D Blosser; Gregory Haber; Eric A Engels
Journal:  Kidney Int       Date:  2020-11-05       Impact factor: 18.998

9.  Comparison of cancer prevalence between patients with glomerulonephritis and the general population at the time of kidney biopsy.

Authors:  Jiwon Ryu; HyunJin Ryu; Sejoong Kim; Ho Jun Chin; Ki Young Na; Dong-Wan Chae; Hyung-Jin Yoon
Journal:  PLoS One       Date:  2019-10-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.